These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 30075571)

  • 1. Excision repair cross-complementing group 1 (ERCC1) overexpression inhibits cell apoptosis and is associated with unfavorable prognosis of esophageal squamous cell carcinoma.
    Peng H; Yao S; Dong Q; Zhang Y; Gong W; Jia Z; Yan L
    Medicine (Baltimore); 2018 Aug; 97(31):e11697. PubMed ID: 30075571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERCC1 single nucleotide polymorphism C8092A, but not its expression is associated with survival of esophageal squamous cell carcinoma patients from Fujian province, China.
    Chen WH; Xin PL; Pan QX; Chen YY; Wang CR; Zhang ZS; Chen YF; Zhang CY; Cai WJ
    PLoS One; 2014; 9(9):e106600. PubMed ID: 25191856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERCC1 expression and tumor regression predict survival in esophageal squamous cell carcinoma patients receiving combined trimodality therapy.
    Ge H; Lu Y; Chen Y; Zheng X; Wang W; Yu J
    Pathol Res Pract; 2014 Oct; 210(10):656-61. PubMed ID: 25042384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.
    Yang X; Wang Q; Dai W; Zhang J; Chen X
    Tumour Biol; 2014 Dec; 35(12):11977-84. PubMed ID: 25142232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of SIRT1 and survivin correlates with poor prognosis in esophageal squamous cell carcinoma.
    Yan L; Zhao Q; Liu L; Jin N; Wang S; Zhan X
    Medicine (Baltimore); 2020 Aug; 99(34):e21645. PubMed ID: 32846774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of survivin over-expression in patients with esophageal squamous cell carcinoma: a meta-analysis.
    Li C; Li Z; Zhu M; Zhao T; Chen L; Ji W; Chen H; Su C
    PLoS One; 2012; 7(9):e44764. PubMed ID: 23028610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.
    Brabender J; Vallböhmer D; Grimminger P; Hoffmann AC; Ling F; Lurje G; Bollschweiler E; Schneider PM; Hölscher AH; Metzger R
    J Gastrointest Surg; 2008 Nov; 12(11):1815-21. PubMed ID: 18769985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Role of Excision Repair Cross-Complementing 1 Gene Expression in Resected Esophageal Squamous Cell Carcinoma: A Meta-Analysis.
    Wang Y; Li J; Shen C; Wu Y; Che G
    Dig Dis Sci; 2020 Aug; 65(8):2264-2271. PubMed ID: 31713119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Rac-1 related to tumor depth, lymph node metastasis and patient prognosis in esophageal squamous cell carcinoma.
    Yang Q; Luo GY; Li Y; Shan HB; Wang HY; Xu GL
    Med Oncol; 2013 Dec; 30(4):689. PubMed ID: 24026656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of biweekly paclitaxel and cisplatin chemotherapy for recurrent or metastatic esophageal squamous cell carcinoma: ERCC1 expression predicts response to chemotherapy.
    Huang J; Zhou Y; Zhang H; Qu T; Mao Y; Zhu H; Quan L; Xing P; Wang J; He J; Xu N; Sun Y
    Med Oncol; 2013 Mar; 30(1):343. PubMed ID: 23263828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirtuin 2 (Sirt2) Expression Predicts Lymph Node Metastasis and Poor Overall Survival of Patients with Esophageal Squamous Cell Carcinoma.
    Yan L; Zhan X; Jia Z; Liu L; Jin N
    Clin Lab; 2018 May; 64(5):669-675. PubMed ID: 29739048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of miRNA-106a expression on the prognosis of patients with esophageal squamous cell carcinoma].
    Yuan JM; Mao WM; Luo J; Peng BF; Zheng ZG; Ling ZQ
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):590-4. PubMed ID: 24314216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ERCC1 and TUBB3 in locally advanced cervical squamous cell cancer and its correlation with different therapeutic regimens.
    Zwenger AO; Grosman G; Iturbe J; Leone J; Vallejo CT; Leone JP; Verdera PP; Pérez JE; Leone BA
    Int J Biol Markers; 2015 Jul; 30(3):e301-14. PubMed ID: 26165688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.
    Wang H; Deng F; Liu Q; Ma Y
    Pathol Res Pract; 2017 Jul; 213(7):842-847. PubMed ID: 28554754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological and predictive significance of SIRT1 and peroxisome proliferator-activated receptor gamma in esophageal squamous cell carcinoma: The correlation with EGFR and Survivin.
    Han F; Zhang S; Liang J; Qiu W
    Pathol Res Pract; 2018 May; 214(5):686-690. PubMed ID: 29625788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer.
    Warnecke-Eberz U; Metzger R; Miyazono F; Baldus SE; Neiss S; Brabender J; Schaefer H; Doerfler W; Bollschweiler E; Dienes HP; Mueller RP; Danenberg PV; Hoelscher AH; Schneider PM
    Clin Cancer Res; 2004 Jun; 10(11):3794-9. PubMed ID: 15173087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
    Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
    Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical significance of REPS2 in human esophageal squamous cell carcinoma.
    Zhang H; Duan CJ; Zhang H; Cheng YD; Zhang CF
    Asian Pac J Cancer Prev; 2013; 14(5):2851-7. PubMed ID: 23803043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.